Cases & Deals

Bayer HealthCare receives antitrust clearance for $1.1 billion Conceptus acquisition

Clients Bayer Healthcare LLC

Jones Day advised Bayer Healthcare LLC on the antitrust aspects of its $1.1 billion acquisition of Conceptus Inc., the California based maker of the Essure® device and a global leader in the development of non-surgical sterilization products. Because the transaction was a cash tender offer, the U.S. Federal Trade Commission (FTC) expedited its review and granted the parties early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.